Professor Eyad Elkord has currently a Professor position with the Department of Biological Sciences, College of Science, Xi'an Jiaotong-Liverpool University, Suzhou, China; and an Honorary Professor position with University of Salford, UK. Before joining XJTLU, he was a Professor of Immunology with the Department of Applied Biology, College of Science, University of Sharjah, United Arab Emirates.

After obtaining his PhD in Tumor Immunology from University of Wales College of Medicine, Cardiff University (UK), he worked as a Postdoctoral Scientist (Jan 2005 - Dec 2007) at the Paterson Institute for Cancer Research, University of Manchester (UK), and was then promoted to a Research Fellow/Group Leader of the Clinical Immunotherapy Laboratory at the University of Manchester (Jan 2008 - Nov 2010). He then undertook a Lecturer position with the University of Salford (Dec 2010 - July 2012) and was promoted in August 2012 to a Senior Lecturer. He moved to the College of Medicine & Health Science, United Arab Emirates University, in 2012 and was an Associate Professor of Immunology until September 2016. He then worked as a Principal Investigator at Qatar Biomedical Research Institute and a Professor at Hamad Bin Khalifa University, Qatar (July 2016 - Nov 2020) and he also had an Honorary Professor position at the Institute of Cancer Sciences-University of Manchester, UK.

Professor Elkord is a member of several highly regarded scientific societies and an editorial board member for peer-reviewed international journals such as Frontiers in Immunology & Oncology (specialty Cancer Immunity & Immunotherapy), BMC Cancer, Vaccines, Heliyon and Journal of Immunology Research. He is the Editor-in-Chief for the newly established journal "Cancer Immunology Connect". He is a reviewer to many international journals and well-known funding agents, such as the UK Medical Research Council, European Research Council, Dutch Research Council. Dr Elkord has more than 135 publications in peer-reviewed high-impact international journals with more than 12300 citations and an h-index of 48 and M-index of 2.7. In recognition of his research influence, Prof. Elkord has been named in Stanford University’s yearly and career global lists of the top 2% of scientists for four consecutive years (2019-2022), achieving the position in the top 0.26% in the Immunology subfield.